ArticleBMJ open2024

Adalimumab vs placebo as add-on to Standard Therapy for autoimmune Uveitis: Tolerability, Effectiveness and cost-effectiveness-a protocol for a randomised controlled trial (ASTUTE trial).

Mae Hazell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.